Neuroblastoma cell-adapted yellow fever virus: mutagenesis of the E protein locus involved in persistent infection and its effects on virus penetration and spread
Persistent infection of mouse neuroblastoma NB41A3 cells with yellow fever 17D virus generates viral variants which exhibit defective cell penetration, poor cell-to-cell spread, small plaque size and reduced growth efficiency, caused by substitution of glycine for aspartic acid or glutamic acid at positions 360 and 362 in the envelope protein. These positions occur within a charge cluster, Asp360-Asp361-Glu362, located in domain III, near its interface with domain I. To characterize further the molecular basis for the variant phenotype, a series of mutant viruses containing substitutions at position 360, 361 and 362, were studied for effects on the cell culture properties typical of the neuroblastoma-adapted variant. Most substitutions at position 360 gave rise to viruses that were very defective in cell penetration, growth efficiency and cell-to-cell spread, whereas substitution with glutamic acid yielded a virus indistinguishable from parental yellow fever 17D. Substitution with lysine was not tolerated and substitution with asparagine resulted in frequent wild-type revertants. A glycine residue was not tolerated at position 361, but substitution at 362 yielded a small plaque virus, similar to the effect of substitution at position 360. These data indicate that the yellow fever virus E protein contains a locus within domain III where a negative-charge cluster is important for optimal function of this domain in virus-cell interactions beyond the stage of virus attachment. Modelling predictions suggest that the mutations alter the local properties of the loop within domain III, and may compromise interactions of this domain with an adjacent region of domain I during conformational changes that occur in the E protein in association with virus entry.
AllisonS. L.,
SchalichJ.,
StiasnyK.,
MandlC. W.,
HeinzF. X.2001; Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 75:4268–4275[CrossRef]
BeasleyD. W.,
AaskovJ. G.2001; Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies. Virology 279:447–458[CrossRef]
BhardwajS.,
HolbrookM.,
ShopeR. E.,
BarrettA. D.,
WatowichS. J.2001; Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol 75:4002–4007[CrossRef]
BressanelliS.,
StiasnyK. S. L.,
AllisonS. L.,
SturaE. A.,
DuquerroyS.,
LescarJ.,
HeinzF. X.,
ReyF. A.2004; Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23:728–738[CrossRef]
CeciliaD.,
GouldE. A.1991; Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181:70–77[CrossRef]
CrillW. D.,
RoehrigJ. T.2001; Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75:7769–7773[CrossRef]
HasegawaH.,
YoshidaM.,
ShiosakaT.,
FujitaS.,
KobayashiY.1992; Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 191:158–165[CrossRef]
HolzmannH.,
StiasnyK.,
EckerM.,
KunzC.,
HeinzF. X.1997; Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J Gen Virol 78:31–37
HurrelbrinkR. J.,
McMinnP. C.2001; Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. J Virol 75:7692–7702[CrossRef]
JacksonR. E.,
PhillpottsR. J.1997; Production of virus-specific antisera using synthetic peptides corresponding to sequences in the yellow fever E protein: brief report. Viral Immunol 10:11–14[CrossRef]
KuhnR. J.,
ZhangW.,
RossmannM. G.9 other authors2002; Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717–725[CrossRef]
LeeE.,
LobigsM.2000; Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol 74:8867–8875[CrossRef]
LobigsM.,
UshaR.,
NestorowiczA.,
MarshallI. D.,
WeirR. C.,
DalgarnoL.1990; Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 176:587–595[CrossRef]
ModisY.,
OgataS.,
ClementsD.,
HarrisonS. C.2003; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986–6991[CrossRef]
NickellsM.,
ChambersT. J.2003; Neuroadapted yellow fever 17D: determinants in the envelope (e) protein govern neuroinvasiveness for SCID mice. J Virol 77:12232–12242[CrossRef]
ReyF. A.,
HeinzF. X.,
MandlC.,
KunzC.,
HarrisonS. C.1995; The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375:291–298[CrossRef]
RiceC. M.1996; Flaviviridae: the viruses and their replication. In Fields Virology , 3rd edn. pp 931–960 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott-Raven;
RiceC. M.,
LenchesE. M.,
EddyS. R.,
ShinS. J.,
SheetsR. L.,
StraussJ. H.1985; Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726–733[CrossRef]
RiceC. M.,
GrakouiA.,
GallerR.,
ChambersT. J.1989; Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol 1:285–296
RoehrigJ. T.1997; Immunochemistry of the dengue viruses. In Dengue and Dengue Hemorrhagic Fever pp 199–219 Edited by
GublerD. J.,
KunoG.
New York: CAB International;
StiasnyK.,
BressanelliS.,
LepaultJ.,
ReyF. A.,
HeinzF. X.2004; Characterization of a membrane-associated trimeric low-pH-induced form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J Virol 78:3178–3183[CrossRef]
Neuroblastoma cell-adapted yellow fever virus: mutagenesis of the E protein locus involved in persistent infection and its effects on virus penetration and spread